A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck

BACKGROUND: Induction chemotherapy (IC) in locally advanced squamous cell carcinoma of the head and neck (LA‐SCCHN) often compromises compliance with subsequent chemoradiotherapy (CRT), which negatively affects outcomes. Here, we assessed the combination of paclitaxel (PTX), carboplatin (CBDCA), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Enokida, Tomohiro, Ogawa, Takenori, Homma, Akihiro, Okami, Kenji, Minami, Shujiro, Nakanome, Ayako, Shimizu, Yasushi, Maki, Daisuke, Ueda, Yuri, Fujisawa, Takao, Motegi, Atsushi, Ohkoshi, Akira, Taguchi, Jun, Ebisumoto, Koji, Nomura, Shogo, Okano, Susumu, Tahara, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050099/
https://www.ncbi.nlm.nih.gov/pubmed/31943834
http://dx.doi.org/10.1002/cam4.2852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050099/
https://www.ncbi.nlm.nih.gov/pubmed/31943834
http://dx.doi.org/10.1002/cam4.2852

Ejemplares similares